ATNF Stock Price, Chart, Stats & News
ETHZilla Corporation Common Stock (ATNF) does not currently pay a dividend.
ATNF chart
Fundamentals
Gross margin | 1.13% |
Operating margin | -5374.29% |
Pretax margin | -5168.17% |
Net margin | -5353.06% |
Effective tax rate | -3.58% |
ROA | -22.30% |
ROE | -192.62% |
D/E | 1.12x |
Interest coverage ratio | -675.78x |
ATNF valuation
P/E | – |
P/S | 256.19x |
P/B | 0.20x |
P/CF | -4.54x |
P/FCF | -56.00x |
P/OCF | -4.54x |
PEG | 0.00x |
EV multiple | -2.92x |
About
1180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to creating treatments for pressing medical challenges including chronic pain, inflammation, fibrosis, and other related inflammatory conditions. The company's therapeutic pipeline is supported by three primary development platforms: An anti-tumor necrosis factor (anti-TNF) and fibrosis platform is progressing through Phase IIb clinical trials, specifically targeting fibrosis and anti-TNF pathways. A Synthetic Cannabidiol (CBD) Analogs platform, featuring laboratory-created derivatives of CBD, is currently in preclinical development.
Similar securities
Based on sector and market capitalization
